ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 657305 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 657305; 2) Community: the network communities that were significantly associated with the response to NSC 657305; 3) Molecule: the relationships between components within communities and NSC 657305; 4) MDR: the compounds that were significantly associated with the NSC 657305.

NSC Compound Enrichment Correlation
NSC 753601 Null 0.0273093708703115 0.22861873
NSC 756220 GW396574X 0.0273093708703115 0.12082185
NSC 761560 N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide 0.0273093708703115 0.076091972
NSC 172614 9H-Purin-2-amine, 9-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]- 0.0287337488682928 -0.035822228
NSC 19441 FDA 0283 0.0287337488682928 0.12590286
NSC 298223 Antibiotic CC 1065 (9CI) 0.0287337488682928 0.1755021
NSC 49520 o-Tolualdehyde, 4-(bis(2-chloroethyl)amino)- 0.0287337488682928 0.17007143
NSC 59620 (4a,6a,9-trimethyl-6,7-dioxo-2,3,4,4b,5,6b,10,10a,11,11a,11b,12,13,13a-tetradecahydro-1H-indeno[2,1-a]phenanthren-2-yl) acetate 0.0287337488682928 0.29937451
NSC 606869 Clofarabine 0.0287337488682928 0.0800984
NSC 618636 Null 0.0287337488682928 0.09318337
Total:71  Current:45    [First] [Prev] [Next] [Last]